Teva Chairman Phillip Frost (C) stands with outgoing CEO Shlomo Yanai (R) and incoming CEO Jeremy Levin during a news conference in Tel Aviv. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Yanai would step down as president and chief executive officer in May. Yanai will be replaced by Levin, a former senior executive at Bristol-Myers Squibb, Teva said in a statement.
No comments:
Post a Comment